XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 82,498 $ 103,093
Accounts receivable-trade, net 650,017 504,122
Accounts receivable-other, net 73,264 55,508
Inventories 222,122 243,286
Financing receivables-net, current 136,294 89,829
Deferred costs 44,258 44,191
Other current assets 60,775 55,101
Total current assets 1,269,228 1,095,130
Financing receivables and operating leases-net 68,582 84,417
Deferred tax asset 3,682 3,682
Property, equipment, and other assets 72,153 70,447
Goodwill 158,199 136,105
Other intangible assets-net 46,942 25,045
TOTAL ASSETS 1,618,786 1,414,826
Current liabilities:    
Accounts payable 295,855 220,159
Accounts payable-floor plan 168,601 134,615
Salaries and commissions payable 38,607 37,336
Deferred revenue 118,910 114,028
Other current liabilities 34,555 24,372
Total current liabilities 700,368 561,326
Non-recourse notes payable - long-term 9,717 9,522
Deferred tax liability 721 715
Other liabilities 62,284 60,998
TOTAL LIABILITIES 773,090 632,561
COMMITMENTS AND CONTINGENCIES (Note 9)
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 per share par value; 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 per share par value; 50,000 shares authorized; 26,942 outstanding at September 30, 2023 and 26,905 outstanding at March 31, 2023 274 272
Additional paid-in capital 173,318 167,303
Treasury stock, at cost, 424 shares at September 30, 2023 and 261 shares at March 31, 2023 (22,375) (14,080)
Retained earnings 693,713 627,202
Accumulated other comprehensive income-foreign currency translation adjustment 766 1,568
Total Stockholders' Equity 845,696 782,265
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 1,618,786 1,414,826
Recourse [Member]    
Current liabilities:    
Notes payable-current 2,016 5,997
Non-recourse [Member]    
Current liabilities:    
Notes payable-current $ 41,824 $ 24,819